celecoxib and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

celecoxib has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Demetris, AJ; Han, C; Leng, J; Wu, T1
Cheang, M; Chen, CS; Dunn, SE; Emerman, J; Gilks, CB; Huntsman, D; Kucab, JE; Lee, C; Pollak, M; Yorida, E; Zhu, J1
Beales, IL; Ogunwobi, O1
Ahn, DW; Cho, SJ; Jung, HC; Kim, CH; Kim, JS; Kim, N; Lee, KS; Lee, MK; Park, JH; Song, IS1
El-Hefnawy, T; Kilic, A; Landreneau, RJ; Luketich, JD; Schuchert, MJ1
Chang, JK; Chou, CH; Ho, ML; Li, CJ; Wang, GJ1
Xia, S; Yu, S; Zhang, M; Zhao, Y1
Bai, J; Chang, W; Du, H; Long, Y; Sun, Z; Tao, K; Tian, S; Wang, H; Zhang, Q; Zhu, G1
Cai, N; Liu, NN; Sun, YZ1

Other Studies

10 other study(ies) available for celecoxib and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

ArticleYear
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Caspase 9; Caspases; Celecoxib; Cell Death; Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Chromones; Cyclooxygenase 2; Cytochromes c; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Immunoassay; Immunohistochemistry; Isoenzymes; Membrane Proteins; Microscopy, Fluorescence; Morpholines; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Sulfonamides; Threonine; Time Factors

2004
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours.
    Breast cancer research : BCR, 2005, Volume: 7, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Cell Survival; Chromones; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Humans; Morpholines; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrazoles; Signal Transduction; Sulfonamides

2005
Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways.
    Molecular and cellular endocrinology, 2006, Mar-09, Volume: 247, Issue:1-2

    Topics: Anthracenes; Apoptosis; Celecoxib; Cell Line, Tumor; Cell Survival; Chromones; Colonic Neoplasms; Gastrins; Humans; Janus Kinase 2; JNK Mitogen-Activated Protein Kinases; Morpholines; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrazoles; Signal Transduction; STAT3 Transcription Factor; Sulfonamides; Transcription Factor AP-1; Tyrosine; Tyrphostins

2006
Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling.
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:3

    Topics: Antineoplastic Agents; Blotting, Western; Caspase 9; Celecoxib; Cell Death; Cell Line, Tumor; Chromones; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indomethacin; Morpholines; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Signal Transduction; Stomach Neoplasms; Sulfonamides; Time Factors

2009
Efficacy of signal pathway inhibitors alone and in combination with Cisplatin varies between human non-small cell lung cancer lines.
    The Journal of surgical research, 2009, Jun-01, Volume: 154, Issue:1

    Topics: Carcinoma, Non-Small-Cell Lung; Celecoxib; Cell Line, Tumor; Chromones; Cisplatin; Cyclooxygenase Inhibitors; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Gossypol; Humans; Lung Neoplasms; Morpholines; Pyrazoles; Signal Transduction; Sulfonamides

2009
The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
    Biochemical pharmacology, 2010, Mar-15, Volume: 79, Issue:6

    Topics: Anti-Inflammatory Agents; Celecoxib; Cell Proliferation; Cells, Cultured; Chromones; Cyclin-Dependent Kinase Inhibitor p27; Dextroamphetamine; Epidermal Growth Factor; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Indomethacin; Male; Morpholines; Osteoblasts; Phosphatidylinositol 3-Kinases; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Pyrazoles; Sulfonamides

2010
Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells.
    Cancer biotherapy & radiopharmaceuticals, 2010, Volume: 25, Issue:3

    Topics: bcl-Associated Death Protein; Celecoxib; Cell Proliferation; Cell Survival; Chromones; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Inhibitors; Gene Expression; HeLa Cells; Humans; Inhibitory Concentration 50; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Signal Transduction; Sulfonamides; X-Rays

2010
The interplay between GRP78 expression and Akt activation in human colon cancer cells under celecoxib treatment.
    Anti-cancer drugs, 2015, Volume: 26, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Celecoxib; Cell Line, Tumor; Chromones; Colonic Neoplasms; Endoplasmic Reticulum Chaperone BiP; Gene Silencing; Heat-Shock Proteins; Humans; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Sulfonamides; Transcription Factor CHOP; Unfolded Protein Response

2015
Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 44, Issue:4

    Topics: Celecoxib; Cell Hypoxia; Cell Line; Cell Proliferation; Chromones; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Down-Regulation; Epithelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction; Vascular Endothelial Growth Factor A

2017